Cargill purchased Bunge's interest in Gramoven for $100 million, pursuant to a stock purchase agreement (the Agreement) dated November 4, 1998. Pursuant to section 2.04 of the Agreement, entitled "Post-Closing Audit and Adjustment," the purchase price was subject to a postclosing adjustment based on Gramoven's net worth as reflected in a "Closing Balance Sheet" to be prepared in accordance with Venezuelan generally accepted accounting principles, at Cargill's option and cost...
Let's get started
Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.